Home › Bladder Cancer › California › Newport Beach
Bladder Cancer clinical trials in Newport Beach, CA
4 studies for Bladder Cancer are looking for participants at sites in and around Newport Beach (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecruitingObservational study
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- Newport Diagnostics Center (Radiology), Newport Beach
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
RecruitingObservational study
- Hoag Memorial Hospital Presbyterian, Newport Beach
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY35 studies
- Houston, TX31 studies
- Nashville, TN31 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Boston, MA26 studies
- Baltimore, MD24 studies
- Los Angeles, CA24 studies
- St. Louis, MO22 studies
- Seattle, WA21 studies
- Edison, NJ21 studies
- Chicago, IL21 studies
Other studies in Newport Beach
- Breast Cancer16 studies
- Non-Small Cell Lung Cancer14 studies
- Metastatic Cancer10 studies
- COPD9 studies
- Ovarian Cancer9 studies
- Endometrial Cancer7 studies
- Lung Cancer7 studies
- Colorectal Cancer6 studies
- Prostate Cancer6 studies
- Triple-Negative Breast Cancer6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.